Logo.png
Biofrontera Inc. announces reduction of Biofrontera AG shareholding to less than 50% through warrant exercises
30 déc. 2021 08h45 HE | Biofrontera Inc.
WOBURN, Mass., Dec. 30, 2021 (GLOBE NEWSWIRE) -- Biofrontera Inc. (Nasdaq: BFRI), a biopharmaceutical company specializing in the commercialization of dermatological products, announced that through...
Logo.jpg
Biofrontera reports Q1 2021 financial results
11 mai 2021 10h41 HE | Biofrontera AG
Leverkusen, Germany, May 11, 2021 (GLOBE NEWSWIRE) -- Biofrontera AG (NASDAQ: BFRA; Frankfurt Stock Exchange: B8F) (the “Company”), an international biopharmaceutical company, today reported its...
Logo.jpg
Biofrontera reports preliminary revenue for the month of April 2021
06 mai 2021 07h23 HE | Biofrontera AG
Leverkusen, Germany, May 06, 2021 (GLOBE NEWSWIRE) -- Biofrontera AG (NASDAQ: BFRA; Frankfurt Stock Exchange: B8F) (the “Company”), an international biopharmaceutical company, today reported...